Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health
Sagility Ltd · Investor Presentation · 22 Oct 2026, 11:58 pm
Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health Sagility delivered solid Q2 FY27 performance with revenue growing 22.5% YoY (12.2% CC) to ₹20,321M ($212.6M). Adjusted EBITDA increased 23.0% YoY to ₹5,353M, expanding margins to 26.3%, while Adjusted PAT rose 8.1% YoY to ₹3,254M. The company secured $40.2M in ACV and announced an interim dividend of ₹0.15 per share. Total debt is on track to be fully repaid in FY27. Additionally, Sagility acquired Chirok Health for $20M upfront plus up to $12.35M contingent consideration to boost Provider segment RCM and CDI capabilities.
Original exchange filing (PDF)
More announcements from Sagility Ltd
- The Company has made grant of stock options under the Employee Stock Options and Performance Stock Units Scheme 2026 of the Company · 14 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 02, 2026 for Sagility BV · 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sagility B.V. · 03 Nov 2026
- Transcript of Earnings Call held on October 22, 2026 · 29 Oct 2026
- Communication to Shareholders regarding TDS on Interim Dividend FY2026-27 · 23 Oct 2026
- Disclosure of Investor Call Recording Q2FY27 · 23 Oct 2026
- Board approves Interim dividend for FY 2026-27 · 23 Oct 2026
- Corporate Action - Record date intimation for Interim dividend FY 2026-27 · 23 Oct 2026
